| Bioactivity | LN-439A (compound LN-439A) is a BAP1 inhibitor that inhibits the growth of basal-like breast cancer by degrading KLF5.[1]. |
| CAS | 2991822-04-7 |
| Formula | C24H26FN3O4 |
| Molar Mass | 439.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wang TT, et al. LN-439A, a novel BAP1 inhibitor, suppresses the growth of basal-like breast cancer by degrading KLF5. Acta Pharmacol Sin. 2024 Oct 8. |